Cephalothin, which has the relatively high serum protein binding of 70%, is metabolized in the human body to 20-30% and rapidly excreted by the kidneys. In contrast cefuroxime which is only bound 35 % to serum proteins has a very low metabolic breakdown rate and renal excretion is much slower. Therefore it can be expected that concentrations of cefuroxime in most tissues and body fluids will be higher than those of cephalothin.
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Methods
In a cross-over study, the pharmacokinetics of both drugs were compared after bolus i.v. injection of I g, and during continuous i.v. infusion of 0.166 g in 10 healthy adult volunteers. Serum, urine and skin blister fluid concentrations were assayed by the agar diffusion technique using Bacillus subtilis (ATCC 6633) and Difco Antibiotic Assay Medium No. 1. Pharmacokinetic constants were calculated in a two compartment open model. Skin blisters were produced by coverings measuring 1 x I cm and containing 0.2 % cantharidin in an ointment. These coverings were fastened on the forearms 12 h before i.v. infusion of each drug. Skin blister fluid (0.2 ml containing 70-80 % of the protein content of serum) was obtained by puncture of two intradermal blisters (once each) with a syringe and a thin needle. Skin blisters always healed within I week without serious sideeffects or scars. Standard curves for antibiotic assay in skin blister fluid, serum and urine were prepared using such fluids from untreated individuals as diluent.
Results
The i.v. bolus injection of 0.75, 1 and 1.5 g of cefuroxime resulted after 0.5 h in mean serum levels of 30, 43 and 61 ,ug/ml, decreasing to concentrations of 0.8, 1.2 and 1.5 g/ml respectively after 6 h ( Table 1) . Areas under the curve were 58, 82 and 102 h.,ug/ml corresponding to the increase of the administered dose.
Thirty min after i.v. injection of 1 g of cephalothin, the mean serum level was significantly lower (2.9 ,Lg/ml) and fell rapidly to <0.1 jug/ml after 3 h. The area under the serum level curve (14.5) was about one-fifth of the area under the curve after i.v. injection of cefuroxime.
Pharmacokinetic constants of cefuroxime and cephalothin are listed in Table 2 . Because of its higher metabolic breakdown rate (30%), cephalothin has a lower calculated initial blood concentration of the active drug (y0=80 ,tg/ml) in comparison to the value for cefuroxime (yo= 124 ,ug/ml). The biological half life (t4) of cefuroxime is 2.5 times greater than that of cephalothin, caused mainly by the slower renal excretion of cefuroxime, shown by the smaller elimination constant (kei), 1.4 in comparison to the value for cefuroxime of 4.2. The elimination constants (kl.2) of cefuroxime and cephalothin which are an expression of the penetration of the drug into the tissues are nearly equal, whereas the elimination constant of cefuroxime (k2.1 -1.35) differed significantly from the calculated value for cephalothin (k2.1=2.37). The constant k2.1 indicates the velocity of back diffusion from the tissues into the blood and from these calculations, Table I Mean concentrations of cefuroxime in serum of 10 healthy adults after i.v. injection of 0.75, 1.0 and 1.5 g of cefuroxime cefuroxime must rediffuse more slowly into the blood than cephalothin. The distribution volume is usually calculated by dividing the administered dose into yo, the extrapolated initial blood concentration. The distribution volume of cephalothin would then be higher (approximately 12.1) than the distribution volume of cefuroxime (8.1). But since one-third of the administered cepahlothin is metabolized in the body, it is more accurate to divide the nonmetabolized component of the cephalothin into y. which results in a distribution volume of 8.31, nearly the same figure as for cefuroxime. It is therefore concluded that active cephalothin present in the blood is distributed to the same degree into the extravascular space as is cefuroxime.
Urine recovery during the 9 h following the i.v.
injection of 1 g of cefuroxime varied in 10 healthy volunteers from 76-99 % (with an average of 89 %). Thus, only a small part of the drug may be excreted by another route or is metabolized in the body. Urine recovery of cephalothin over 9 h was determined as 60 %.
During continuous i.v. infusion of 0.166 g of cephalothin, constant serum levels were obtained earlier than after continuous i.v. infusion of cefuroxime (at 1 as opposed to 2.5 h, Table 3 ).
The mean serum concentration of cephalothin in the steady state was 2.8 jug/ml, that of cefuroxime being 5-6 times higher, at 13.1 fig/ml. Total clearance of cefuroxime was calculated as 232 ml/min; total clearance of cepahlothin as 1010 ml/min. Renal clearance of cefuroxime Table 3 Mean concentration of cefuroxime and cephalothin in serum and skin blister fluid of 7 healthy adults during and after continuous i.v.infusion of 0.166 g/h for 4 h. Cefazolin 78-902 9.0 1.9
25.1 -0.9 36 averaged 132 ml/min; renal clearance of cephalothin 766 ml/min. At the end of continuous i.v. infusion, skin blister fluid contained 1.5 ,ug/ml of cephalothin and 12.0 ,xg/ml of cefuroxime. One hour later the mean concentration of cephalothin in skin blister fluid was only one-tenth of the mean skin blister concentration of cefuroxime.
Comparison of 5 cephalosporins in our laboratory is of particular interest with respect to blood levels in the steady state and to skin blister concentrations. At a dose of 0.166 g/h serum concentration after 4 h of i.v. infusion is highest in cefazolin (25 ,ug/ml), followed by cefuroxime (13.1 ,tg/ml), cefamandole (8.1 ,tg/ml), cephradine (4.8 ,ug/ml). and lowest with cephalothin (2.8 ,ug/ml). Skin blister concentration was highest with cefuroxime, the ratio between skin blister fluid and serum being 92 %. Intravenous infusion of cefradine resulted in a mean skin blister concentration of 3.5 ,ug/ml and a mean serum concentration of 4.8 ,ug/ml giving a ratio of 73 %. In experiments with cefamandole and cephalothin skin blister fluid contained 4.5 and 1.5 ,ug/ml, giving ratios of 56% and 54% respectively. The biggest difference between skin blister fluid and serum was found with cefazolin (36 % Table 4 ).
With respect to penetration into skin blister fluid, there was no strong correlation between the calculated ratio and the protein binding of the drug. Despite the strong protein binding of cefazolin, total skin blister concentrations were high in comparison to the other cephalosporins and despite the low protein binding of cephradine, total skin blister concentrations were low. High 21 skin blister concentrations of cefuroxime seem to be most favourable for penetration into exudates from inflamed skin blisters. In order to evaluate the tissue penetration of cefuroxime at all, it is necessary to investigate antibiotic concentrations in different tissues and body fluids.
